Nandrolone decanoate (ND) is a synthetic steroid, which promotes adverse effects on the ovarian tissue, and melatonin (MLT) exhibits a number of beneficial properties in the reproductive system. This study evaluated the general features of the ovarian tissue and the immunoexpression of sex steroid receptors in ND-treated rats that were submitted to short-term melatonin treatment. Adult rats received mineral oil (control group) and ND at doses of 7.5 mg/kg for 15 days (ND-treated group). The treatment with MLT (10mg/kg for 7 days) was given alone, before or in combination with ND. All ND-treated animals showed persistent dioestrus. In the androgenized groups that received MLT, ovarian morphology and size, and the number/area of corpora lutea were recovered. The number of healthy and atretic follicles was recovered when MLT was administered prior to ND; this was similar to the ovaries of control and MLT groups. There was a decrease in estrogen receptors immunostaining in the follicles of androgenized rats that were treated with MLT, and pretreatment with MLT reduced the expression of androgen receptor in atretic follicles and corpora lutea, when compared with ND-treated group. We conclude that MLT treatment recovered the histopathological aspects of the androgenized ovaries, and MLT pretreatment was the most effective.
number of atretic follicles, and decrease in the number of corpora lutea and follicles in maturation process. [7] [8] [9] [10] Several studies have focused attention on the use of chemical agents with the ability to reduce or suppress the side effects promoted by toxicants. In this context, melatonin (N-acetyl-5-methoxytryptamine) (MLT), a neurohormone secreted by the pineal gland at night, has important antioxidant, immunomodulatory and hormonal properties in diverse systems and organs. 11, 12 The actions of MLT are mediated by the membrane receptors (MT1 and MT2) or nuclear receptors (RZR/ ROR family), which influence the daily and seasonal rhythms of physiological and behavioural processes. 13, 14 In mammals,
MLT can regulate the reproductive function through the hypothalamic-pituitary-gonadal axis. 13 In addition, MLT is found in the fluid of the ovarian follicles and has a direct action on the gonadal function, especially related to the processes of cellular differentiation and steroidogenesis. 15, 16 Previous study showed that MLT has a protective effect against oxidative stress in the granulosa cells, thus contributing to luteinization and progesterone production. 17 Treatment with exogenous doses of MLT alters the reproductive function, which induces differential regulation of AR, ERα and ERβ, and progesterone (PRA and PRB) receptors in the ovaries and uterus, in addition to protect ovarian tissue against the lipid peroxidation during ovulation in animal models 16, 18, 19 and humans. 20 MLT also prevents and controls some pathological conditions, such as endometriosis, polycystic ovarian syndrome and premature ovarian failure after exposure to chemotherapy or radiation therapy. 15, [21] [22] [23] In addition, the protective effect of MLT has been previously reported in the ovaries of nicotine-treated rats, 12 in the uterus and oviduct of mice exposed to nicotine, 24 and in the ovarian follicles undergoing radiation. 25 To date, there are no reports regarding the possible protective effect of MLT on androgenized ovaries. Considering that ND affects the reproductive capacity by promoting adverse effects on the ovarian tissue, and that MLT exhibits several functional properties at the molecular level, this study evaluated qualitatively and quantitatively the ovarian tissue, and the immunoexpression of sex steroid receptors (AR, ERα and ERβ) in the ovaries of ND-treated rats that were submitted to short-term MLT treatment.
| METHODS

| Animals
Forty Wistar rats, 12 weeks old, and~260 g, were purchased from the São Paulo State University (UNESP-Botucatu, SP, Brazil) and kept at the Central Bioterium of the School of Sciences, Humanities and Languages (UNESP-Assis, SP, Brazil). The animals were housed in polypropylene cages (45 cm × 30 cm × 15 cm, four animals/cage) with pine shavings as bedding and maintained under appropriate conditions of temperature (23 ± 1°C) and lighting (12-h light/dark cycle, 200 lux). Water and commercial diet (Nuvilab ™ , Colombo, PR, Brazil) were provided ad libitum.
| Ethical approval
The experimental protocol followed the ethical principles in animal research adopted by the Brazilian College of Animal Experimentation and was approved by the Ethical Committee for Animals Use of the School of Sciences, Humanities and Languages (UNESP-Assis, SP, Brazil; Permit Number: 005/2014).
| Chemicals
Nandrolone decanoate (17β-hydroxy-19-nor-4-androstene-3-one), available as Deca-Durabolin ™ , was purchased from Schering-Plow Laboratory (São Paulo, Brazil). ND is an oily injectable solution, containing 50 mg of the androgen. Melatonin (N-acetyl-5-methoxytryptamine) was purchased from Sigma-Aldrich Laboratory (Saint Louis, MO, EUA). Each 10 mg of MLT was dissolved in 0.1 mL of 95% ethanol and diluted in 0.3 mL of 0.9% NaCl (vehicle) to the final concentration of 25 mg/mL.
26,27
| Experimental protocol
Females displaying regular oestrous cycle were weighed and randomly divided into five experimental groups (n = 8/group; Figure 1 ): (a) Control (C), treated with subcutaneous (s.c.) injection of 0.1 mL mineral oil (vehicle) for 15 consecutive days; (b) treated with ND, via s.c., at a dose of 7.5 mg/kg body weight (b.w.), diluted in vehicle, once daily for 15 consecutive days; (c) treated with mineral oil injection, via s.c., for 8 days followed by intraperitoneal injection (i.p.) of MLT at the dose of 10 mg/kg b.w., during the last 7 days of the experimental period; (d) treated with ND, via s.c., for 15 consecutive days and co-administration of MLT, via i.p., in the last 7 days of the ND treatment (ND/MLT); (e) pretreatment with MLT, via i.p., for seven consecutive days, followed by treatment with ND, via s.c., for 15 consecutive days (MLT/ND). Injections of mineral oil and ND were given in the same time interval (12:30-13:00 p.m.), and MLT treatment was administered at the beginning of the dark phase (18:30-19 :00 p.m.).
| Selection of dosages
The supraphysiological dose of 7.5 mg ND/kg was selected based on previous studies using animals, 5, 28 which simulates the conditions commonly employed by non-therapeutic users of AAS (ranging from 250 to 3200 mg/week). 29 The chosen dose of 10 mg MLT/kg was based on the SOUZA ET AL.
| 159 studies by Baykara et al 30 and Chabra et al 31 and showed functional and protective reproductive responses.
| Evaluation of the oestrous cycle
Oestrous cycle was monitored daily by cytological examination of the material obtained through the vaginal aspiration technique. 32 The collection time was fixed at 12:00-13:00 p.m. Slides containing the detaching cells of the vaginal epithelium were analysed under a light microscope (Olympus CX31 RBSFA, Tokyo, Japan), and the phases of the oestrous cycle were identified according to the criteria described by Goldman et al. 33 
| Tissue preparation
After the experimental period, animals were weighed and euthanized by anaesthetic saturation in CO 2 followed by decapitation. The ovaries and uterine horns were collected and weighed, and relative weights were obtained (reproductive organ weight/b.w. × 100, expressed as g/100 g b.w.). The ovaries were fixed in 10% buffered formalin (0.2 M NaH 2 PO 4 , 0.2 M Na 2 HPO 4 , 37% formaldehyde, pH 7.2; LABIMPEX Ltda., São Paulo, Brazil) for 24 h. The tissue was then dehydrated in graded ethanol series, clarified in xylene and embedded in paraffin (Paraplast, Labware-Oxford, St. Louis, MO, USA). The 4-μm-thick semi-serial sections were prepared using a microtome (Leica, RM2125, Germany), and stained with haematoxylin-eosin (H&E). For histopathological analysis, four equidistant ovarian sections of each animal were examined, and the follicular types were classified according to Pedersen and Peters. 34 For immunohistochemical analysis, the ovarian sections were transferred to a microwave (700-800 W) while immersed in 0.01 M sodium citrate buffer (pH 6.0) for antigen recovery. After blocking the endogenous peroxidase, tissue was incubated with 3% bovine serum albumin (BSA, 3%) for 1 h to prevent non-specific binding. All sections were incubated in a humid chamber overnight at 4°C with primary antibody anti-AR (dilution 1: 100, NB300-551, Novus Biologicals, Littleton, CO, USA), anti-estrogen receptor alpha (ER-α) (dilution 1: 100, NB110-56961, Novus Biologicals, Littleton, CO, USA) and anti-estrogen receptor beta (ER-β) (dilution 1 μg/mL, NB120-3577, Novus Biologicals). After reactions, the slides were washed in phosphate-buffered saline (pH 7.0) and incubated with the secondary antibody (Anti-Mouse Polymer IgG or anti-Rabbit-DAKO CYT) at room temperature for 1 h. Finally, the slides were placed to react with diaminobenzidine (DAB; Sigma, St. Louis, MO, USA) for 5 min, and then, the sections were counterstained with Harris haematoxylin. Negative controls were obtained by omitting the primary antibody. The slides were examined blinded using a Zeiss Axio Scope-A1 microscope (Carl Zeiss Jena, Germany) using the following colour intensity criteria: absent (−), weak (+), moderate (++) and strong (+++). Digital images were acquired using a light microscope (Axio Scope A1-coupled to a video camera AxioCam ICc3) and digitalized by AxioVision software version 4.7.2 (Carl Zeiss, Germany).
| Morphometric analysis
Semi-serial sections of the two ovaries (right and left ovary) were obtained from the whole organ. Four equidistant sections, stained with H&E, were randomly selected in each ovary by animal (eight females/group), totalling 64 replicates in the experimental group, for each parameter evaluated. The healthy/atretic follicles and corpora lutea were quantified. For the identification and classification of healthy follicles, the criterion described by Hirshfield 35 was chosen as follows:
Class I (small preantral follicles with a diameter smaller than 90 μm); Class II (large preantral follicles with a diameter between 91 and 260 μm); Class III (small antral follicles with a diameter between 261 and 350 μm); Class IV (mediumsized antral follicles, 351-430 μm); Class V (large antral follicles with a diameter between 431 and 490 μm); Class VI (mature or Graafian follicles with a diameter >491 μm).
The criterion for the identification of atretic follicles was based on the degree of degeneration of the antral follicles, according to the classification described by Osman, 36 which considers the following: shrinkage of the granulosa layer and degenerative changes (Stage IA); degeneration of the granulosa layer and presence of nuclear fragments in the periphery of the antrum (Stage IB); degenerate oocyte surrounded by an envelope of cumulus cells or their remnants (Stage IIA); and oocyte in the antrum, with the granulosa layer usually consisting of a thin coating and usual presence of macrophages in the antrum (Stage IIB). The corpora lutea were quantified, and the perimeter (area) was estimated. Measurements of diameter of healthy follicles and corpora lutea were obtained using the Zeiss A1-Axio microscope coupled to an AxioCam ICc3 video camera. The images were digitalized using the software AxioVision, version 4.7.2 (Carl Zeiss, Jena, Germany). All analyses were performed in a double-blind test.
| Statistical analysis
Shapiro-Wilk normality test was applied to all data. For parametric data, analysis of variance (ANOVA) complemented by Tukey's test was used, and the results were expressed as mean ± standard deviation (SD). For nonparametric data, Kruskal-Wallis test complemented by StudentNewman-Keuls test was used, and the results were expressed as median ± interquartile deviation. Statistical significance was set at P < 0.05. Statistical analysis was performed using GraphPad Prism software, version 5.00 (GraphPad Software Inc., San Diego, CA, USA).
| RESULTS
| Melatonin did not synchronize oestrous cycle but restored ovarian weight
The animals of the different experimental groups presented no variation (P < 0.05) in the final body weight (Figure 2A ). Treatment with ND alone or in combination with MLT promoted a significant increase (P < 0.05) in the number of days in dioestrus phase compared to the control and MLT-treated groups only ( Figure 2B ). There was no significant difference (P > 0.05) among groups receiving ND. Notably, MLT-treated animals presented regular oestrous, with number of days in dioestrus phase similar to the C group. Due to the persistence of the dioestrus phase in androgenized groups, all females were killed at this same stage of the cycle, including those from the C and MLT-treated groups.
The ovarian relative weight was significantly decreased only in the ND-treated animals ( Figure 2C ). The MLT, ND/MLT and MLT/ND groups showed no differences in the ovarian weights. Conversely, there was Figure 2D ). The MLT group presented uterine weight similar (P > 0.05) to the C group.
| Ovarian morphology is recovered when melatonin is administered before ND
The females of control ( Figure 3A ) and melatonin-treated groups ( Figure 3B ) presented normal features of ovarian morphology, characterized by a cortex with many follicles in maturation and developing corpora lutea. The lutein cells ( Figure 3B ) presented rounded nucleus, prominent nucleolus and abundant cytoplasm. The medulla ( Figure 3A ) exhibited wide vascularization and constituted for loose connective tissue. In ND-treated animals ( Figure 3C,D) , there were histopathological changes characterized by intense follicular atresia, lack of corpora lutea and follicles in maturation, and presence of follicular cysts. These cysts were larger than the preovulatory follicles displaying a thin layer of flat cells resting on a fibrous membrane ( Figure 3D ). Ovarian atrophy and dilated or congested blood vessels were common in the medulla, and corpora lutea showed poor development and fibrous appearance in the central area ( Figure 3C ).
The ND/MLT group ( Figure 3E ,F) presented ovarian histology different from the ND-treated group, as it exhibited well-developed and vascularized corpora lutea (Figure 3E ). However, follicles in different stages of Values expressed as the mean ± standard deviation. ANOVA, Tukey's test (n = 4 sections/ovary/animal/group). Groups: C (Control), MLT (treated with melatonin), ND (treated with nandrolone decanoate), ND/MLT (treated with steroid prior to melatonin) and MLT/ND (pretreatment with melatonin followed by ND treatment). *P < 0.05 vs other groups.
degeneration were notable as well as occasionally were observed follicular cysts ( Figure 3F ). Moreover, dilated blood vessels were observed in the medulla and cortex ( Figure 3E ). The ovaries of MLT/ND group ( Figure 3G ,H) developed corpora lutea with high vascularization (Figure 3H ), and health follicles in diverse stages of maturation. Furthermore, there was absence of cystic follicles and medullar vasodilation ( Figure 3G) . Morphologically, the ovarian tissue presented similar features to that of the control group, thus reflecting a positive response of MLT given prior to ND treatment. 
| Development of follicle and corpora lutea varied according to melatonin treatment
The quantitation of healthy follicles in the different class of maturation is shown in Figure 4A . In ND-treated animals, the frequency of class II, III and IV follicles was reduced (P < 0.05) compared with control, MLT and MLT/ND groups; follicles in later stages of maturation (classes V and VI) were absent. The ND/MLT group presented significant decrease in number of classes IV, V and VI follicles, in comparison with the C, MLT and MLT/ND groups, while for classes II and III the result was similar (P > 0.05). However, the previous treatment with MLT (MLT/ND group) maintained a follicular frequency equivalent to the C group for all of the maturation stages. MLT-treated animals had a similar frequency of the control group as to the healthy follicles in the different classes. ND and ND/MLT groups presented significantly higher number of atretic follicles with advanced degree of atresia (stage IIB) than the other experimental groups.
The number and area of the corpora lutea were significantly reduced (P < 0.05) in the ND-treated group, compared to the other experimental groups (Table 1) . Importantly, treatment with MLT in the androgenized groups (MLT/ND and ND/MLT) resulted in the restoration of the number and area of corpora lutea similarly to the C and MLT groups.
| Sex steroid receptors are differently regulated by melatonin in the androgenized ovaries
Immunolocalization of ovarian sex steroid receptors (AR, ERα and ERβ) is presented in Table 2 and Figures 5, 6 ,
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Immunostaining for AR in the ovaries of the different experimental groups. Control group (A) showed moderate staining intensity in healthy follicles (f; in detail) and corpora lutea (CL; in detail). In the MLT group (B), the follicles (f) and corpora lutea (CL) presented weak and strong immunostaining respectively. In C is shown the strong staining intensity in atretic follicles (At) and corpora lutea (CL) of the ND group. In the ND/MLT group (D), the reaction for AR in corpora lutea (CL) and atretic follicles (At) was strong while in MLT/ND group (E), it was moderate in follicles (f) and corpora lutea (CL; in detail). In (F), atretic follicles exhibited low marking in the MLT group, while in the ND (G), and ND/MLT (H) groups, the atretic follicles were strongly marked. In (I, J and K), the lutein cells of the MLT, ND and ND/MLT groups, presented strong immunostaining for AR. Bars = 200 μm (A-E) and 50 μm (F-K and details in A, E) [Colour figure can be viewed at wileyonlinelibrary.com] and 7 respectively. The immunostaining for AR in the C ( Figure 5A ) and MLT/ND groups ( Figure 5E ) was moderate in granulosa, theca cells, and oocytes of healthy follicles in all maturation stages (primary, growing and antral; Figure 5A ), and also in atretic follicles and lutein cells ( Figure 5A ,E). In MLT-treated animals ( Figure 5B,F) , growing, antral and atretic follicles presented low intensity of AR immunostaining in the granulosa and theca cells, while in the ND ( Figure 5C ,G) and ND/MLT groups (Figure 5D ,H), AR staining was strong in granulosa cells of atretic follicles. The lutein cells of MLT ( Figure 5I ), ND ( Figure 5J ) and ND/MLT ( Figure 5K ) groups exhibited high AR intensity. Interstitial tissue, epithelium and tunica albuginea presented moderate, strong and low staining intensity for AR in all experimental groups respectively.
The granulosa cells and oocytes from healthy and atretic follicles, corpora lutea and interstitial tissue presented moderate ERα immunostaining in the C (Figure 6A,F) and ND-treated groups ( Figure 6C,G) . In the MLT ( Figure 6B,I ), ND/ MLT ( Figure 6D ,J) and MLT/ND ( Figure 6E,K) , there was low intensity of staining in granulosa cells of healthy follicles in the different maturation stages (primary, growing and antral) and atretic follicles, but the moderate ERα immunostaining in the corpora lutea was maintained ( Figure 6B,D,E) . In the ND group, the corpora lutea exhibited moderate ERα immunostaining ( Figure 6C ). The follicular cysts ( Figure 6C , H) observed in the ND and ND/MLT animals presented moderate ERα expression in granulosa cells. Ovarian epithelium exhibited strong immunostaining regardless of the experimental groups, and tunica albuginea presented no ERα staining.
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Immunostaining for ERα in the ovaries of the different experimental groups. In the control group (A), the healthy follicles (f) and corpora lutea (CL) showed moderate staining intensity. In the MLT group (B), the corpora lutea (CL) presented moderate reaction, whereas a low reaction appeared in the follicles. In the ND group (C), atretic follicles (At), corpora lutea (CL) and follicular cysts (FC) exhibited moderate staining. In the ND/MLT (D) and MLT/ND (E) groups, the follicles (f) showed weak immunostaining and corpora lutea (CL) exhibited moderate staining. In detail (A-E) is shown the immunostaining for ERα in lutein cells of each group. In F (control group) and G (ND group), antral follicles showed a moderate immunoreaction to ERα. In the MLT (I), ND/MLT (J) and MLT/ND (K) groups, the reaction was weak in the antral follicles. In H (ND group) is shown a follicular cyst with moderate ERα immunolabelling. Bars = 200 μm (A-E, H) and 50 μm (F, G, I-K and details in A-E) [Colour figure can be viewed at wileyonlinelibrary.com]
Regarding the immunolocalization of ERβ in the C group ( Figure 7A,F) , granulosa, theca cells and oocytes of healthy and atretic follicles showed moderate labelling, while in the corpora lutea there was a strong ERβ expression ( Figure 7J ). In the MLT-treated group (Figure 7B,G) , the healthy and atretic follicles exhibited low ERβ immunostaining in granulosa cells, similarly to the ND/MLT (Figure 7D,H) and MLT/ND ( Figure 7E,I ) groups. The animals that received only ND treatment ( Figure 7C ) had moderate expression of healthy and atretic follicles in granulosa cells. However, the lutein cells of few corpora lutea ( Figure 7K ) showed low ERβ immunostaining. Except the tunica albuginea, which showed absence of reaction, the epithelium and follicular cysts showed moderate ERβ immunostaining in all experimental groups.
| DISCUSSION
This study investigated whether MLT treatment is able to protect the ovarian tissue of ND-treated animals from the injuries caused by the androgenic anabolic steroid, as previously reported in our past studies 8, 37 ; the helpful effect of MLT was considered based on the previous studies involving reproduction. 12, 25, 38 MLT has been described to exert a number of functions in the control of reproductive physiology. [38] [39] [40] In this study,
(I) (J) (K)
F I G U R E 7
Immunostaining for ERβ in the ovaries of the different experimental groups. In (A), the moderate immunostaining in healthy follicles (f) and strong staining in corpora lutea (CL) in the control group is observed. In the MLT group (B), the follicles (f) exhibited weak immunoreaction and the corpora lutea (CL) presented strong staining intensity (lutein cells in detail). In (C) (ND group), the moderate intensity in the corpora lutea (CL), atretic follicles (At; in detail) and follicular cysts is observed (FC). In the ND/MLT (D) and MLT/ND (E) groups, the corpora lutea (CL) maintained the strong staining intensity (lutein cells in detail), but the follicles (f) were weakly marked. In F (control group) is shown the moderate reaction in the antral follicle, compared to antral follicles of the MLT (G), ND/MLT (H) and MLT/ND (I) groups, which exhibit low staining intensity. In the lutein cells of the control group (J), there was strong ERβ immunolabelling, while in the ND group (K), this immunolabelling was moderate. Bars = 200 μm (A-E) and 50 μm (F-K and details in B-E) [Colour figure can be viewed at wileyonlinelibrary.com]
MLT treatment did not promote changes in the oestrous cycle of rats, contributing to the previous reports by Chuffa et al 19 and Bondi et al 41 However, treatment with 10 mg MLT/kg for 60 days in rats 18 or 300 mg MLT for 4 months in women 42 suppressed ovarian function by decreasing LH secretion and release. Treatment with different doses of ND is capable of promoting oestrous acyclicity. 43, 44 In this study, the persistence of the dioestrus stage occurred even in androgenized groups that were treated with MLT. Due to the increase in circulating androgens, the control of the hypothalamicpituitary-ovary axis is often disturbed; as a result, there is inhibition of gonadotropin and oestrogen releasing, thus causing irregularities in the oestrous cycle. 7, 28 Simão et al 44 reported that treatment with 7.5 mg ND/ kg induced LH hypersecretion followed by an increase in testosterone and dihydrotestosterone levels, while FSH remained unchanged. In addition, oestrogen levels increased due to the interference of the drug in the synthesis of estradiol, mediated by the aromatase enzyme, whose concentrations were higher in the androgenized groups. Thus, androgens not only alter aromatase activity but also serve as a substrate for oestrogen synthesis. 45, 46 This hormonal profile is linked to oestrous acyclicity in rats, similar to that reported by Gervásio et al 47 in which an excessively androgenic ovarian microenvironment (eg polycystic ovary syndrome-PCOS) may have a negative impact on follicular development; in addition to the androgenic status, LH hypersecretion found in PCOS results in chronic anovulation and infertility. The increase in LH and FSH levels has also been reported in transsexual patients treated with synthetic androgenic steroids. 48 In this study, the final body weight of animals was not influenced by the treatments. Previous studies have shown no effect of synthetic steroids on the final body weight of rats, corroborating with our results. 5, 28, 43 Mostafavi et al 49 identified that melatonin as an adjunctive treatment has a buffering role on the side effects of several drugs on body weight. However, long-term melatonin treatments during 60 days 18 or 105 days 50 reduced body weight in rats. In this study, we showed that treatment with 10 mg/kg of melatonin for 7 days does not alter the final body weight, in agreement with other studies that used similar dose and period. [51] [52] [53] The reduction in ovarian weight of rats treated with synthetic steroid is likely due to the atrophy of the organ and impaired folliculogenesis and luteogenesis, thus confirming previous findings. 37, 54 The administration of MLT recovered the ovarian weight in the androgenized animals, as there was follicular development and corpora lutea formation. It is documented that MLT decreases LH levels, 19 whereas treatment with 7.5 mg ND/kg may increase the levels of this gonadotropin. 44 In this study, treatment with MLT might have balanced the LH levels that were deregulated by the steroid, attenuating the damages on the ovarian function. In addition, the protective effect of MLT on ovaries against oxidative damage 16, 18 and toxic agents 12, 25 was also confirmed by this study, considering the dose and experimental protocol used. The increase in uterine weight in the ND-treated animals was reflected in several histopathological changes, as reported in previous studies. 5, 10, 43 Treatment with MLT did not restore uterine weight in androgenized groups. In fact, a preliminary study 55 showed that the rats receiving ND associated with MLT treatment had compromised uterine tissue due to the excess of circulating androgen. As previously reported, 10,37 the damage to folliculogenesis in females receiving only ND was evidenced by intense follicular atresia, absence of mature antral follicles and decrease in the number of healthy follicles at different stages of maturation. There were presence of cystic structures mainly in the ND group and occasionally in the ND/ MLT group, resulting from deregulation in hormonal balance and ovulation failure. 44 However, mature healthy follicles were identified, but in the ND/MLT group, the more developed follicles were less frequent than those observed in the control, MLT and MLT/ND groups. The number of atretic follicles in the more advanced stage of degeneration was lower in MLT/ND than in ND/MLT group, and follicular cysts were absent in the group previously treated with MLT.
Although the role of MLT in the hypothalamic-pituitary-gonadal axis has not yet been fully elucidated, it is reported that the influence of MLT is greater on the ovulation process than on follicular growth. 40 In this study, folliculogenesis was altered by ND and reversed by MLT, mainly in the MLT/ND group, whereas in the ND group, there was intense follicular atresia induced by an excess of circulating androgens (testosterone and DHT). 44 Treatment with AAS promotes an imbalance between reactive oxygen species (ROS) and anti-oxidants, resulting in oxidative stress and, consequently, damage in different organs, such as kidneys, testes and the cardiovascular system. [56] [57] [58] This action is likely due to the direct binding of the synthetic steroid to AR, which can cause damage to the mitochondria. 59 Minaii et al 60 reported that MLT attenuates the oxidative stress and the damage to male gametes of ND-treated rats subjected to forced swimming exercise. Thus, the most positive result obtained by pretreatment with MLT can be explained by the anti-oxidant properties of this agent and its metabolites in oocytes and granulosa cells of the ovarian follicles, as described by other authors 17, 18, 40 ; this resulted in the prevention of follicles and corpora lutea degeneration. In the present study, luteogenesis was severely affected by ND, similarly to our previous reports. 8, 37 In addition, when the androgenized animals received the MLT treatment, there was a recovery in the number and area of the corpora lutea in the ND/MLT and MLT/ND groups. The decline in progesterone secretion promoted by the androgenic treatment is associated with degeneration of luteal structures. 7, 44 Thus, the beneficial action of MLT on luteogenesis can be explained by its positive correlation with progesterone secretion, 40, 61 despite no association with estradiol or testosterone synthesis was found. Taketani et al 17 reported that MLT contributed to the luteinization and synthesis of progesterone in human cells. In addition, MLT may also trigger upregulation of progesterone receptors. 19, 38 Furthermore a previous study by Romeu et al 38 showed a beneficial effect of MLT on the luteogenesis of ovaries displaying some aspects of PCOS in rats. Treatment with MLT alone led to weak AR expression in healthy and atretic follicles, whereas in the ND and ND/ MLT groups, an increase in the AR expression was observed in the atretic follicles. In MLT/ND-treated animals, AR expression was moderate in the degenerating follicles. The increase in follicular AR expression in rats treated with synthetic steroids was reported by Chadha et al 62 and Simão et al 44 which is related to the detrimental effects on folliculogenesis through the direct action of the steroid on its receptor. Chuffa et al 19 reported a decreased AR expression in the fallopian tube of rats treated with MLT. In our study, the MLT/ ND group showed AR expression in the same intensity of the control group, suggesting that melatonin is able to decrease AR expression after an upregulation promoted by ND. In the corpora lutea of the MLT, ND and ND/MLT groups, the cells showed increased AR expression, suggesting that both steroid and MLT have a positive effect on this receptor. However, pretreatment with MLT in the ND-treated group did not result in differences in the AR immunostaining compared with control group. AAS exerts a direct negative effect on folliculogenesis through AR and indirectly via ER. 63, 64 In the present study, all groups that received MLT had weak immunostaining for ERα and ERβ in healthy and atretic follicles, while in the ND-treated group the expression of ER was similar to the control group, showing that MLT was responsible for the decrease in the expression of these receptors. The decreased regulation of ER promoted by MLT has been previously reported in ovaries, fallopian tube and uterus of rats treated with doses of 0.8 mg/kg for 15 days 65 and 1 mg/kg for 60 days. 19 The corpora lutea of rats treated with ND alone showed a decrease in the ERβ immunostaining, compared to the other experimental groups. This result suggests that MLT had a regulatory effect on the ERβ expression induced by ND treatment in the corpora lutea. Therefore, it is possible to state that both MLT and ND differentially affected the folliculogenesis and luteogenesis.
Complementary studies are needed to verify hormonal levels and MLT receptors in order to elucidate the complex mechanisms by which MLT and ND concomitantly modulate ovarian activity.
In conclusion, MLT had a beneficial effect on the ovaries of rats treated with ND, evidenced by the recovery of folliculogenesis and luteogenesis. Sex steroid receptors were differently regulated by MLT in the ovarian follicles and corpora lutea. The pretreatment with MLT was most effective compared to the concomitant treatment with the synthetic steroid.
